SEARCH VEGSOURCE:

 

 

Follow Ups | Post Followup | Back to Discussion Board | VegSource
See spam or
inappropriate posts?
Please let us know.
  




From: TSS (216-119-144-68.ipset24.wt.net)
Subject: NHS: vCJD and Hepatitis C Lord Morris of Manchester asked Her Majesty's Government:
Date: October 22, 2004 at 2:25 pm PST

-------- Original Message --------
Subject: NHS: vCJD and Hepatitis C Lord Morris of Manchester asked Her Majesty's Government:
Date: Fri, 22 Oct 2004 15:47:37 -0500
From: "Terry S. Singeltary Sr."
Reply-To: Bovine Spongiform Encephalopathy
To: BSE-L@UNI-KARLSRUHE.DE


##################### Bovine Spongiform Encephalopathy #####################

Thursday 21 Oct 2004


NHS: vCJD and Hepatitis C

Lord Morris of Manchester asked Her Majesty's Government:

How many people the Department of Health have warned that they may
be at increased risk of developing vCJD as a result of National
Health Service treatment; to how many haemophilia patients the
warning has been sent; and how many such patients have already
been infected with hepatitis C by contaminated National Health
Service blood products.[HL4357]

The Parliamentary Under-Secretary of State, Department of Health (Lord
Warner): In England, 15 recipients of whole blood products were notified
in December 2003 of their possible increased risk of variant
Creutzfeldt-Jakob disease.

For recipients of plasma products, the patient notification exercise was
started on 21 September, and is still in progress. For people with
haemophilia, patient records need to be examined to see which plasma
products they have received since 1980. Clinicians treating these
patients are currently examining records for around 6,000 people. This
will take some time to complete. There are no data available yet on how
many of those people have been notified.

21 Oct 2004 : Column WA101

It is estimated that there are currently about 3,000 people with
haemophilia who are infected with hepatitis C through contaminated blood
and blood products.

For people outside this group, individual risk assessments need to be
completed once patients have been identified as being a recipient of an
affected product. Trusts are working with the Health Protection Agency
to trace recipients and complete risk assessments. This exercise is
expected to take several months. There are no data available yet on
numbers of people who may need to be notified.

http://www.publications.parliament.uk/

TSS

################# BSE-L-subscribe-request@uni-karlsruhe.de #################





Follow Ups:



Post a Followup

Name:
E-mail: (optional)
Subject:

Comments:

Optional Link URL:
Link Title:
Optional Image URL: